Milnacipran - Xconomy

by in

Entry	Author	Date	Location
Cypress Bioscience, After Months of Give and Take, Agrees to a $255M Buyout	Bruce V. Bigelow	12/15/10	San Diego
Cypress Bio Rejects Buyout Again, Calls Offer Opportunistic, Undervalued	Bruce V. Bigelow	09/28/10	San Diego
In Appeal to Cypress Bio Stockholders, Ramius Raises Buyout Offer	Bruce V. Bigelow	09/15/10	San Diego
Cypress Shipping Fibromyalgia Drug	Bruce V. Bigelow	05/11/09	San Diego
San Diego Biotechs With Good News Step Forward at Roth Conference	Bruce V. Bigelow	02/18/09	San Diego
Cypress Bioscience Shares Soar on News of FDA Approval	Bruce V. Bigelow	01/15/09	San Diego
Cypress Bioscience Drug Succeeds in Fibromyalgia Study	Luke Timmerman	12/08/08	San Diego
Cypress Fibromyalgia Drug Stalled by FDA	Luke Timmerman	10/20/08	San Diego
Cypress Bioscience, Developer of Fibromyalgia Drug, Eagerly Awaits FDA Deadline	Luke Timmerman	10/10/08	San Diego
Page 1 of 1

Xconomy National